Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Tacrolimus Formulations on Insulin Secretion in Kidney Transplant Recipients
NCT01092806Phase 4Completed
- Sponsor
- University of Oslo School of Pharmacy
- Start
- Oct 2009
- Primary completion
- May 2010
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by University of Oslo School of Pharmacy. Started Oct 2009; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01092806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092806.